Clinical Trial Update: Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Acute Stroke Infarct [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update covers a Phase 1/2 study evaluating a combination of conditioned medium and umbilical cord-derived mesenchymal stem cells for ischemi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Conditioned medium (conditioned medium)
• Umbilical cord-derived mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: PT. Prodia Stem Cell Indonesia | Conditions: Ischemic Stroke | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING